Get started
DANAHER CORPORATIONDANAHER CORPORATIONDANAHER CORPORATION

DANAHER CORPORATION

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals Bonds

DHR trade ideas

$DHR WILL BE A GREAT SHORT ON ANY MARKET WEAKNESSDespite the acquisition of GE Biopharma the stock performance this year is hard to quantify, it does seem that it has ran a little too far to fast and needs a healthy pullback. We assume that when the selling does start it could snowball into quite a drop as large profits are banked and sellers find it hard to offload their portfolio. We will be looking at this as a short when the indicators become more oversld. AVERAGE ANALYSTS PRICE TARGET $144 AVERAGE ANALYSTS RECOMMENDATION OVERWEIGHT P/E RATIO 41 COMPANY PROFILE Danaher Corp. operates as a medical company, which designs, manufactures, and markets professional, medical, industrial and commercial products and services. It operates through the following five segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions. The Life Sciences segment offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines. The Diagnostics segment comprises of analytical instruments, reagents, consumables, software, and services that hospitals, physician's offices, reference laboratories, and other critical care settings use to diagnose disease and make treatment decisions. The Dental segment develops products and services that are used to diagnose, treat and prevent disease and ailments of the teeth, gums, and supporting bones; as well as to improve the aesthetics of the human smile. The Environmental & Applied Solution segment offers products and services that help protect important resources and keep global food and water supplies safe. The company was founded by Steven M. Rales and Mitchell P. Rales in 1969 and is headquartered in Washington, DC.
NYSE:DHR
by RedHotStocks
DHR Danaher Corp. Possible 10%+ Upside Trend/Resistance line: DHR Has recently overtaken a long-term resistance trendline starting in 2010 on the weekly chart and is currently using it as a loose support trendline. The chart, on both the weekly and daily timeframes, is showing an ascending wedge, with the stock gaining momentum we should see the price move past the resistance made in the 103.60-104.00 range. MACD (12, 26, close): The MACD indicator is showing a bullish signal on the weekly, assuming the current price action remains the same we should see this crossing be confirmed within the next two weeks. Not only does the weekly MACD look promising but the daily does as well, making higher bullish crossings, signaling increasing momentum. RSI(14): RSI on both daily and weekly have overtaken the 50 mark, again signaling the gain of momentum, which will be vital for breaking past resistance. FIB lines: Weekly fib lines have been marked on the chart, with the red being possible stops and green as my current price target, which loosely aligns with analyst recommendations. Daily chart supports these targets as well, although slightly lower at a price target of 108.00
NYSE:DHRLong
by odeaolay
1
Long DHR in consolidationThe daily chart of DHR looks to be in the final stages of a Wave-4 triangle. Alternation between Wave-2 and Wave-4 of the impulsive move is a good sign. This means Wave-2 was a deep, zig-zag correction compared to a shallow, sideways correction in Wave-4. A topside break of the triangle should lead to higher prices in Wave-5. Initiating a long position with an immediate profit target at 105 (with an extension up to 107.50). A move below 95 invalidates the setup.
NYSE:DHRLong
by UnknownUnicorn182749
1